
French Tech 120 - Promotion 2024
Lancé en 2019 par la Mission French Tech, le French Tech Next40/120 est un programme d’accompagnement de l’État dédié aux 120 start-up françaises les plus performantes, en capacité de devenir leaders de rang international. Elles bénéficient pendant un an d’un accompagnement en lien avec leurs enjeux de développement en France et à l’international.
French Tech 120
2024

AQEMIA
Scale drug discovery with quantum-inspired physics and generative AI AQEMIA is a drug invention company dedicated to novel medicines — never me-toos — tackling major diseases such as oncology. Our physics-based, generative AI platform invents drug candidates beyond the reach of traditional R&D, without dependence on experimental data. We are … [voir plus]

DNA Script
Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s … [voir plus]

ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics an @Ipsen company designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. [voir plus]

Moon Surgical
Moon Surgical développe une plateforme d'assistance à la laparoscopie qui augmente les capacités du chirurgien tout en optimisant l'utilisation des ressources dans le bloc opératoire. [voir plus]

Pasqal
Defining the quantum reality. We build Programmable Quantum Simulators and Quantum Computers made of 2D and 3D Atomic Arrays. Neutral atoms trapped in optical tweezers and addressed with laser beams are ideal indistinguishable quantum systems to realize superposition and entanglement, at the heart of powerful Quantum Information Processing. It is … [voir plus]

PROPHESEE
Metavision Technologies Prophesee is the inventor of the world’s most advanced neuromorphic vision systems. The company developed a breakthrough event-based vision approach to machine vision that enables dramatic reductions in power consumption, latency, and data processing requirements. By mimicking how the human eye and brain work, Prophesee’s patented Metavision® sensors … [voir plus]

SiPearl
Microprocesseurs haute performance et basse consommation souverains pour le supercalcul, l'IA et les centres de données SiPearl est le spécialiste européen « fabless » des microprocesseurs haute performance et basse consommation souverains pour le supercalcul, l'IA et les centres de données. Ces microprocesseurs permettront de relever des défis stratégiques dans … [voir plus]

TISSIUM
Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, … [voir plus]

TreeFrog Therapeutics
Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant … [voir plus]

Shift Technology
The leading AI platform for insurance Shift delivers AI agents that transform insurers' most critical work. By combining deep industry expertise and unmatched data resources, Shift provides proven results that have earned the trust of hundreds of the world's leading insurers. Our insurance-grade AI is accurate, explainable, and secure—empowering human … [voir plus]